Cano Health's Q2 Miss and Restructuring: Shares Take a Hit
- August 11th, 2023
- 377 views
Cano Health, Inc. (NYSE: CANO) reported a Q2 2023 loss of $(0.51) per share, which fell short of the consensus estimate loss of $(0.12). The company's quarterly sales were also below expectations, totaling $766.70 million while analysts projected $828.43 million for the period.
Cano Health also unveiled plans to sell itself, accompanied by the decision to discontinue operations in California, New Mexico, Illinois by fall 2023, and Puerto Rico by the end of the year. The company is implementing a comprehensive operational restructuring plan aimed at enhancing efficiency and reducing costs. As part of this restructuring, Cano Health is projected to downsize its workforce by about 700 employees, which constitutes 17% of its total workforce, in the third quarter of 2023.
$CANO was trading at $0.86 in pre-market, reflecting a significant decline of $0.66 or 43.42%
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Tags
Post Your Comments
Want To Find Some News?
Recent Posts
-
NJCP National Football Conference Names David Dalton Head Coach of Salt Lake Yeti
February 06th, 2026FDA Takes New Approach to "No Artificial Colors" Claims
February 06th, 2026NJCP National Football Conference Announces Micah Deckart as Head Coach of the Idaho Outlaws
February 05th, 2026




Member Login